PPARG and Alzheimer disease: There are abundant evidences to support the beneficial effects of PPAR-γ activation against neurodegenerative diseases, including AD (45-48); however the electrophysiological mechanisms by which PPAR-γ activation prevents Aβ-induced functional alterations and the possibility of the use of its agonists at the early stages of AD have not been fully elucidated.